JP2005526104A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526104A5 JP2005526104A5 JP2003581751A JP2003581751A JP2005526104A5 JP 2005526104 A5 JP2005526104 A5 JP 2005526104A5 JP 2003581751 A JP2003581751 A JP 2003581751A JP 2003581751 A JP2003581751 A JP 2003581751A JP 2005526104 A5 JP2005526104 A5 JP 2005526104A5
- Authority
- JP
- Japan
- Prior art keywords
- tablet according
- additional excipients
- tablet
- cyclodextrin
- cetirizine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37008602P | 2002-04-04 | 2002-04-04 | |
| PCT/IB2003/001130 WO2003084511A1 (en) | 2002-04-04 | 2003-03-26 | Palatable chewable tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005526104A JP2005526104A (ja) | 2005-09-02 |
| JP2005526104A5 true JP2005526104A5 (cg-RX-API-DMAC7.html) | 2006-04-27 |
Family
ID=28792024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003581751A Pending JP2005526104A (ja) | 2002-04-04 | 2003-03-26 | 味の良い咀嚼可能な錠剤 |
Country Status (23)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2354688T3 (es) * | 2002-01-15 | 2011-03-17 | Ucb Farchim S.A. | Formulaciones para la administración oral de compuestos activos. |
| US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| EP1758856A2 (en) | 2004-05-04 | 2007-03-07 | Novo Nordisk A/S | Indole derivatives for the treatment of obesity |
| CA2574602A1 (en) * | 2004-07-22 | 2006-02-02 | Pfizer Products Inc. | Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| PL2486942T3 (pl) | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
| WO2007144902A1 (en) * | 2006-06-12 | 2007-12-21 | Jubliant Organosys Limited | Chewable bilayer tablet formulation |
| EP2178521B1 (en) * | 2007-07-11 | 2014-01-15 | Fertin Pharma A/S | Stable medicated chewing gum comprising cyclodextrin inclusion complex |
| WO2009006892A1 (en) * | 2007-07-11 | 2009-01-15 | Fertin Pharma A/S | Stable medicated chewing gum comprising antioxidant |
| EP2178522A1 (en) * | 2007-07-11 | 2010-04-28 | Fertin Pharma A/S | Compressed chewing gum tablet comprising taste-masking agent |
| CL2008003230A1 (es) * | 2007-11-01 | 2009-11-27 | Sanofi Aventis Healthcare Pty Ltd | Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta. |
| CN102711739B (zh) | 2009-11-13 | 2015-12-16 | 阿斯利康(瑞典)有限公司 | 双层片剂 |
| WO2011110939A2 (en) | 2010-03-11 | 2011-09-15 | Rubicon Research Private Limited | Pharmaceutical compositions of substituted benzhydrylpiperazines |
| WO2013129436A1 (ja) * | 2012-02-29 | 2013-09-06 | 武田薬品工業株式会社 | 経口剤 |
| PL2861236T3 (pl) | 2012-06-15 | 2020-03-31 | Pharmathen S.A. | Kompozycja farmaceutyczna zawierająca polimer wiążący fosforany |
| CN102716099B (zh) * | 2012-07-05 | 2013-10-09 | 湖南千金湘江药业股份有限公司 | 盐酸左西替利嗪咀嚼片及其制备方法 |
| CA2882950A1 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| WO2016033424A1 (en) | 2014-08-29 | 2016-03-03 | Genzyme Corporation | Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b |
| JP2016094364A (ja) * | 2014-11-14 | 2016-05-26 | ニプロ株式会社 | 安定化および苦味抑制された口腔内崩壊製剤 |
| EP3061501A1 (en) | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Composition for the treatment of acne |
| EP3117825A1 (en) | 2015-07-16 | 2017-01-18 | Rottapharm S.p.A. | Oral formulation comprising berberine and morus alba extract |
| JP2019001730A (ja) * | 2017-06-13 | 2019-01-10 | 武田テバファーマ株式会社 | 安定な経口医薬組成物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3558600A (en) | 1967-07-28 | 1971-01-26 | Abbott Lab | Alkyl sulfate salts of 1-(p-chlorobenzhydryl)-4-methylhomopiperazines |
| NO155805C (no) | 1981-02-06 | 1987-06-10 | Ucb Sa | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter. |
| US4650663A (en) | 1983-07-20 | 1987-03-17 | Warner-Lambert Company | Magnesium trisilicate suitable for preparation of medicament adsorbates of antitussives |
| US4792448A (en) | 1987-06-11 | 1988-12-20 | Pfizer Inc. | Generic zero order controlled drug delivery system |
| IL91398A (en) | 1988-08-30 | 1994-05-30 | Pfizer | Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane |
| DE9190107U1 (de) | 1990-08-07 | 1993-12-16 | Pfizer Inc., New York, N.Y. | Abgabe-Vorrichtung mit durch Grenzflächen-Polymerisation erhaltenen Membranen |
| CA2146637C (en) | 1992-10-09 | 2001-02-13 | James Grigg Upson | Pharmaceutical compositions and methods for treating cold symptoms |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US6027746A (en) * | 1997-04-23 | 2000-02-22 | Warner-Lambert Company | Chewable soft gelatin-encapsulated pharmaceutical adsorbates |
| BE1011251A3 (fr) * | 1997-07-03 | 1999-06-01 | Ucb Sa | Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine. |
| DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
| US6270790B1 (en) | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
| US7223421B2 (en) * | 2000-06-30 | 2007-05-29 | Mcneil-Ppc, Inc. | Teste masked pharmaceutical particles |
| US20030035839A1 (en) * | 2001-05-15 | 2003-02-20 | Peirce Management, Llc | Pharmaceutical composition for both intraoral and oral administration |
| ES2354688T3 (es) * | 2002-01-15 | 2011-03-17 | Ucb Farchim S.A. | Formulaciones para la administración oral de compuestos activos. |
-
2003
- 2003-03-26 ES ES03745693T patent/ES2298540T3/es not_active Expired - Lifetime
- 2003-03-26 CN CNB038070448A patent/CN100335041C/zh not_active Expired - Fee Related
- 2003-03-26 EP EP03745693A patent/EP1494654B1/en not_active Expired - Lifetime
- 2003-03-26 WO PCT/IB2003/001130 patent/WO2003084511A1/en not_active Ceased
- 2003-03-26 DE DE60319685T patent/DE60319685T2/de not_active Expired - Lifetime
- 2003-03-26 AT AT03745693T patent/ATE388693T1/de not_active IP Right Cessation
- 2003-03-26 PL PL03372904A patent/PL372904A1/xx not_active Application Discontinuation
- 2003-03-26 CA CA002481025A patent/CA2481025A1/en not_active Abandoned
- 2003-03-26 IL IL16410603A patent/IL164106A0/xx unknown
- 2003-03-26 BR BR0308927-4A patent/BR0308927A/pt not_active IP Right Cessation
- 2003-03-26 KR KR10-2004-7015586A patent/KR20040098036A/ko not_active Ceased
- 2003-03-26 RU RU2004129573/15A patent/RU2004129573A/ru not_active Application Discontinuation
- 2003-03-26 MX MXPA04009617A patent/MXPA04009617A/es active IP Right Grant
- 2003-03-26 JP JP2003581751A patent/JP2005526104A/ja active Pending
- 2003-04-01 US US10/404,964 patent/US7482022B2/en not_active Expired - Fee Related
- 2003-04-02 TW TW092107552A patent/TW200401651A/zh unknown
- 2003-04-02 PE PE2003000337A patent/PE20030950A1/es not_active Application Discontinuation
- 2003-04-02 UY UY27746A patent/UY27746A1/es not_active Application Discontinuation
- 2003-04-03 AR ARP030101167A patent/AR039242A1/es unknown
- 2003-04-03 HN HN2003000112A patent/HN2003000112A/es unknown
- 2003-04-04 PA PA20038570601A patent/PA8570601A1/es unknown
-
2004
- 2004-09-17 ZA ZA200407537A patent/ZA200407537B/en unknown
- 2004-11-03 NO NO20044774A patent/NO20044774L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2004129573A (ru) | Жевательная таблетка с приятным вкусом | |
| Strickley et al. | Pediatric drugs—a review of commercially available oral formulations | |
| JP2002503267A (ja) | スルホアルキルエーテルシクロデキストリンと治療剤との物理的混合物を含有する固形製剤 | |
| JP2009521523A (ja) | 口中溶解性医薬組成物およびその製造方法 | |
| JP2005518405A5 (cg-RX-API-DMAC7.html) | ||
| JP6301460B2 (ja) | レボセチリジンおよびモンテルカストを含む、改善された安定性を有する複合顆粒製剤 | |
| JP2003531118A5 (cg-RX-API-DMAC7.html) | ||
| TW201302248A (zh) | 穩定的口內崩散型膜調配物 | |
| CA2569674A1 (en) | Sublingual buccal effervescent | |
| JP2004525928A5 (cg-RX-API-DMAC7.html) | ||
| JP2005519891A5 (cg-RX-API-DMAC7.html) | ||
| WO2007108010B1 (en) | Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate | |
| EP1863443A2 (en) | Rapidly disintegrating dosage form comprising magnesium carbonate heavy | |
| US20190231685A1 (en) | Antihistamine oral film dosage form and method of administrating same | |
| JP5630902B2 (ja) | ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法 | |
| JP2023013438A5 (cg-RX-API-DMAC7.html) | ||
| JP2016503066A5 (cg-RX-API-DMAC7.html) | ||
| JP4190769B2 (ja) | 内服液組成物 | |
| JP2005525089A5 (cg-RX-API-DMAC7.html) | ||
| JP2008500287A5 (cg-RX-API-DMAC7.html) | ||
| JP2004043475A (ja) | 経口用セファロスポリン製剤 | |
| JP2002326936A5 (cg-RX-API-DMAC7.html) | ||
| JP2002277470A5 (cg-RX-API-DMAC7.html) | ||
| JP2000178204A (ja) | ホスフォジエステラ―ゼ阻害剤を含有する口腔内速崩壊性錠剤 | |
| JP4351359B2 (ja) | ステビア抽出物を配合したｈ２受容体拮抗剤含有製剤 |